Concepedia

Vladimir Beljanski

VB

Statistics

Publications

24

Citations

1.6K

H-Index

19

Active since

1997

Affiliations

Nova Southeastern University(Current)

McGill University

Medical University of South Carolina

Vaccine & Gene Therapy Institute of Florida

Jewish General Hospital

Vladimir Beljanski is an author at Nova Southeastern University specializing in medicine, immunology, and engineering.

ORCID

Top concepts

Publications per year

1997–2022

24

Publications

24

Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2

Kevin J. French, Yan Zhuang, Lynn W. Maines et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 309 citations · Full text

Cellular Oxidative Stress Response Controls the Antiviral and Apoptotic Programs in Dengue Virus-Infected Dendritic Cells

David Olagnier, Suraj Peri, Courtney Steel et al. · PLoS Pathogens · 2014 · 238 citations · Full text

, , +21

A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor Cells

Vladimir Beljanski, Christian Knaak, Charles D. Smith · Journal of Pharmacology and Experimental Therapeutics · 2010 · 110 citations · Full text

Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts

Vladimir Beljanski, Clayton S. Lewis, Charles D. Smith · Cancer Biology & Therapy · 2011 · 102 citations · Full text

Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists

Cindy Chiang, Vladimir Beljanski, Kevin Yin et al. · Journal of Virology · 2015 · 87 citations · Full text

1–5 of 24